Package 51662-1240-2

Brand: narcan naloxone hci

Generic: narcan naloxone hci
NDC Package

Package Facts

Identity

Package NDC 51662-1240-2
Digits Only 5166212402
Product NDC 51662-1240
Product ID 51662-1240_07627f49-62b7-7d91-e063-6294a90a796d
Description

2 VIAL, SINGLE-DOSE in 1 PACKAGE (51662-1240-2) / .1 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2018-10-15
Brand narcan naloxone hci
Generic narcan naloxone hci
Sample Package No

Linked Drug Pages (1)

NARCAN NALOXONE HCI ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "07627f49-62b7-7d91-e063-6294a90a796d", "openfda": {"upc": ["0369547353025"], "unii": ["F850569PQR"], "rxcui": ["1725059"], "spl_set_id": ["784a0e98-c2d6-f845-e053-2991aa0ac4b4"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": ".1 mL in 1 VIAL, SINGLE-DOSE (51662-1240-1)", "package_ndc": "51662-1240-1", "marketing_start_date": "20181015"}, {"sample": false, "description": "2 VIAL, SINGLE-DOSE in 1 PACKAGE (51662-1240-2)  / .1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1240-2", "marketing_start_date": "20181015"}], "brand_name": "NARCAN NALOXONE HCI", "product_id": "51662-1240_07627f49-62b7-7d91-e063-6294a90a796d", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1240", "generic_name": "NARCAN NALOXONE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NARCAN NALOXONE HCI", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "4 mg/.1mL"}], "application_number": "NDA208411", "marketing_category": "NDA", "marketing_start_date": "20181015", "listing_expiration_date": "20261231"}